Sunday, January 30, 2022 7:05:55 AM
Buyout? Anything is possible. A lot of small cap bios are ripe for value buys by big pharma. The tax write offs alone, are probably worth more than what the current market cap is for VCNX.
Recent VCNX News
- Vaccinex Reports 2023 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 04/02/2024 12:30:00 PM
- Vaccinex, Inc. Announces $1.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules • GlobeNewswire Inc. • 03/27/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/04/2024 09:19:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/21/2024 03:10:30 PM
- Vaccinex Announces Multiple New Agreements for Access to ActivMAb® Antigen Virus Technology • GlobeNewswire Inc. • 02/21/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 01:06:03 PM
- Vaccinex, Inc. Announces Reverse Stock Split • GlobeNewswire Inc. • 02/15/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/13/2024 09:30:34 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 02/13/2024 09:15:59 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 02/12/2024 09:22:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:34:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:32:53 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/09/2024 09:08:11 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 02/08/2024 01:20:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/07/2024 08:43:55 PM
- Vaccinex Announces Pricing of $3.7 Million PIPE Financing • GlobeNewswire Inc. • 02/07/2024 01:00:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 01/22/2024 05:15:30 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/19/2024 09:40:09 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 01/10/2024 10:16:22 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 01/08/2024 09:16:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/28/2023 09:31:17 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 12/28/2023 09:15:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/12/2023 09:31:18 PM
- Nasdaq Grants Vaccinex Extension Until March 4, 2024 to Regain Compliance with Listing Rule • GlobeNewswire Inc. • 12/04/2023 01:00:00 PM
- Vaccinex Reports Third Quarter 2023 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 11/13/2023 01:00:00 PM
FEATURED Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • Apr 25, 2024 8:52 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM